Importer of Controlled Substances; Notice of Application, 64743-64744 [2010-26454]
Download as PDF
<![CDATA[
64743
Federal Register / Vol. 75, No. 202 / Wednesday, October 20, 2010 / Notices
comments relating to the 2010 report
and possible content of the 2011 report.
The 2010 report can now be
accessed and downloaded from the
Commission’s Web site at https://
www.usitc.gov/tradeshifts/. The format
used by the Commission since 2004
includes links to Commission research
and other resources including data, as
well as links to other organizations with
related information. User feedback on
the revised format is encouraged by
providing access to the ITC online
Reader Satisfaction Survey (https://
reportweb.usitc.gov/reader_survey/
readersurvey.html).
A CD–ROM version of the 2010 report
may be requested by contacting the
Office of the Secretary at 202–205–2000
or by fax at 202–205–2104. Readers of
the report may also provide comments
by downloading the survey form and
business reply mailer for this
publication from the Commission’s Web
site.
ADDRESSES: All Commission offices,
including the Commission’s hearing
rooms, are located in the United States
International Trade Commission
Building, 500 E Street, SW.,
Washington, DC 20436. All written
submissions should be addressed to the
Secretary, United States International
Trade Commission, 500 E Street, SW.,
Washington, DC 20436. The public
record for this investigation may be
viewed on the Commission’s electronic
docket (EDIS) at https://www.usitc.gov/
secretary/edis.htm.
FOR FURTHER INFORMATION CONTACT:
Project leader, Brendan Lynch (202–
205–3313 or brendan.lynch@usitc.gov)
or deputy project leader, Michelle
Koscielski (202–205–3489 or
michelle.koscielski@usitc.gov). For
information on the legal aspects, please
contact William Gearhart, Office of
General Counsel (202–205–3091 or
william.gearhart@usitc.gov). The media
should contact Margaret O’Laughlin,
Public Affairs Officer (202–205–1819 or
margaret.olaughlin@usitc.gov). Hearing
impaired individuals are advised that
information on this matter can be
obtained by contacting the TDD
terminal on 202–205–2648.
Background: The Commission has
prepared and published annual reports
on U.S. trade shifts in selected
industries/commodity areas under
investigation No. 332–345 since 1993.
Beginning in 2004, the Commission
converted the report to an exclusively
Web-based format (with added focus on
sectoral issues) that can be accessed
electronically. The initial notice of
institution of this investigation was
published in the Federal Register of
emcdonald on DSK2BSOYB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:17 Oct 19, 2010
Jkt 223001
September 8, 1993 (58 FR 47287). The
Commission expanded the scope of this
investigation to cover services trade in
a separate report, which it announced in
a notice published in the Federal
Register of December 28, 1994 (59 FR
66974). The merchandise trade report
has been published in the current series
under investigation No. 332–345
annually since September 1993.
This year’s Web-based format
identifies the key trends affecting
principal foreign markets and 10 major
U.S. sectors.
By order of the Commission.
Issued October 15, 2010.
William R. Bishop,
Acting Secretary to the Commission.
[FR Doc. 2010–26364 Filed 10–19–10; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than November 19, 2010.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: October 8, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–26447 Filed 10–19–10; 8:45 am]
BILLING CODE 4410–09–P
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on August
25, 2010, ISP Freetown Fine Chemicals,
238 South Main Street, Assonet,
Massachusetts 02702, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Phenylacetone (8501), a
basic class of controlled substance listed
in schedule II.
The company plans to import the
controlled substance to manufacture
amphetamine.
Any bulk manufacturers who are
presently, or are applying to be,
registered with DEA to manufacture
such basic class of controlled substance
may file comments or objections to the
issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on September 3, 2010, Johnson
Matthey, Inc., Pharmaceutical Materials,
2003 Nolte Drive, West Deptford, New
Jersey 08066–1742, made application by
renewal to the Drug Enforcement
Administration (DEA) for registration as
an importer of the basic classes of
controlled substances listed in schedule
II:
Drug
Phenylacetone (8501) ..................
Coca Leaves (9040) .....................
Thebaine (9333) ...........................
Opium, raw (9600) .......................
Noroxymorphone (9668) ..............
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
II
II
The company plans to import the
listed controlled substances as raw
materials for use in the manufacture of
bulk controlled substances for
distribution to its customers.
No comments, objections, or requests
for any hearings will be accepted on any
application for registration or reregistration to import crude opium,
poppy straw, concentrate of poppy
straw, and coca leaves. As explained in
E:\FR\FM\20OCN1.SGM
20OCN1
64744
Federal Register / Vol. 75, No. 202 / Wednesday, October 20, 2010 / Notices
the Correction to Notice of Application
pertaining to Rhodes Technologies, 72
FR 3417 (2007), comments and requests
for hearings on applications to import
narcotic raw material are not
appropriate.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act (21 U.S.C.
952(a)(2)(B)) may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than November 19, 2010.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745), all applicants for
registration to import a basic classes of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR § 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: October 8, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–26454 Filed 10–19–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
emcdonald on DSK2BSOYB1PROD with NOTICES
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
VerDate Mar<15>2010
17:17 Oct 19, 2010
Jkt 223001
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on
September 15, 2010, Hospira Inc., 1776
North Centennial Drive, McPherson,
Kansas 67460–1247, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Remifentanil (9739), a
basic class of controlled substance listed
in schedule II.
The company plans to import
Remifentanil for use in dosage form
manufacturing.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic class of controlled substance
may file comments or objections to the
issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than November 22, 2010.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745), all applicants for
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: October 8, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–26445 Filed 10–19–10; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on August 20, 2010,
Cayman Chemical Company, 1180 East
Ellsworth Road, Ann Arbor, Michigan
48108, made application by renewal to
the Drug Enforcement Administration
(DEA) as a bulk manufacturer of the
basic classes of controlled substances
listed in schedule I:
Drug
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Schedule
I
I
The company plans to manufacture
small quantities of marihuana
derivatives for research purposes. In
reference to drug code 7360
(Marihuana), the company plans to bulk
manufacture cannabidiol. In reference to
drug code 7370
(Tetrahydrocannabinols), the company
will manufacture a synthetic THC. No
other activity for this drug code is
authorized for registration.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than December 20, 2010.
Dated: October 8, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–26468 Filed 10–19–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on September 14,
2010, GE Healthcare, 3350 North Ridge
Avenue, Arlington Heights, Illinois
60004–1412, made application by
E:\FR\FM\20OCN1.SGM
20OCN1
]]>Agencies
[Federal Register Volume 75, Number 202 (Wednesday, October 20, 2010)]
[Notices]
[Pages 64743-64744]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-26454]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this
is notice that on September 3, 2010, Johnson Matthey, Inc.,
Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey
08066-1742, made application by renewal to the Drug Enforcement
Administration (DEA) for registration as an importer of the basic
classes of controlled substances listed in schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Phenylacetone (8501)....................... II
Coca Leaves (9040)......................... II
Thebaine (9333)............................ II
Opium, raw (9600).......................... II
Noroxymorphone (9668)...................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances as raw
materials for use in the manufacture of bulk controlled substances for
distribution to its customers.
No comments, objections, or requests for any hearings will be
accepted on any application for registration or re-registration to
import crude opium, poppy straw, concentrate of poppy straw, and coca
leaves. As explained in
[[Page 64744]]
the Correction to Notice of Application pertaining to Rhodes
Technologies, 72 FR 3417 (2007), comments and requests for hearings on
applications to import narcotic raw material are not appropriate.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedule I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in
the circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than November 19, 2010.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, (40 FR 43745), all applicants
for registration to import a basic classes of any controlled substances
in schedule I or II are, and will continue to be, required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and
21 CFR Sec. 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: October 8, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-26454 Filed 10-19-10; 8:45 am]
BILLING CODE 4410-09-P
